P062 Histone Deacetylase 1 (HDAC1): A Novel Therapeutic Target in Rheumatoid Arthritis

doi 10.1136/annrheumdis-2018-ewrr2019.52
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

P116 Histone Deacetylase 1: A Novel Therapeutic Target for Patients With Rheumatoid Arthritis

2018English

Histone Deacetylase 8 as a Novel Therapeutic Target in Oral Squamous Cell Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2016English

Progranulin: A Promising Therapeutic Target for Rheumatoid Arthritis

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2011English

Histone Deacetylase 1 (HDAC1) Regulates Histone Acetylation, Development, and Gene Expression in Preimplantation Mouse Embryos

Developmental Biology
Developmental BiologyCell BiologyMolecular Biology
2008English

Purification of Active Recombinant Human Histone Deacetylase 1 (HDAC1) Overexpressed in Escherichia Coli

Biotechnology Letters
Applied MicrobiologyBiotechnologyMedicineBioengineering
2018English

KCa1.1 (BK) Channels on Fibroblast-Like Synoviocytes: A Novel Therapeutic Target for Rheumatoid Arthritis

Biophysical Journal
Biophysics
2015English

Checkpoint With Forkhead and Ring Finger Domains (CHFR); Histone Deacetylase 1 (HDAC1)

Science-Business eXchange
2009English

Histone Deacetylase HDAC1/HDAC2-controlled Embryonic Development and Cell Differentiation

International Journal of Developmental Biology
EmbryologyDevelopmental Biology
2009English

Blocking Histone Deacetylase Activity as a Novel Target for Epithelial Barrier Defects in Allergic Rhinitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy